Episode 266: Questions, questions, questions PART IV
In episode 266, James and Mike finally get to the end of listener questions. We talk about NSAIDs and inflammation, cognitive impairment and statins, dosing of antibiotics, antidepressants and efficacy, and antiplatelets and ethnicity. We give answers which either clarify or confuse the issues.
1) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2) Selective publication of antidepressant trials and its influence on apparent efficacy
3) Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics